Literature DB >> 12195372

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.

Anna R Giuliano1, Robin Harris, Rebecca L Sedjo, Susie Baldwin, Denise Roe, Mary R Papenfuss, Martha Abrahamsen, Paula Inserra, Sandra Olvera, Kenneth Hatch.   

Abstract

The natural history of type-specific human papillomavirus (HPV) infections was examined in a cohort of 331 women aged 18-35 years who self-referred for routine gynecological care. Participants underwent a gynecological examination at baseline and at approximately 4 and approximately 10 months after baseline. Cervical samples were collected for HPV testing and genotyping at each visit, as was information on reproductive, sexual, and medical histories. The rate of new HPV infections was 2.9% per month; the highest rates were observed for HPV types 16, 39, 84, and 51. Among women who tested negative for HPV at baseline, the cumulative probability of acquiring an oncogenic HPV strain during a 12-month follow-up period was 0.32, compared with 0.18 for nononcogenic strains. Women who had had >/=1 new male sex partner in the recent past were significantly more likely to acquire a new HPV infection (relative hazard, 2.39; 95% confidence interval, 1.20-4.76). The median time to clearance of infection was significantly longer for oncogenic strains (9.8 months) than for nononcogenic strains (4.3 months).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195372     DOI: 10.1086/341782

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  68 in total

1.  Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11.

Authors:  Manjula Singh; Deepshi Thakral; Hemanta Kumar Kar; Narayan Rishi; Prafulla Kumar Sharma; Dipendra Kumar Mitra
Journal:  Virusdisease       Date:  2017-05-20

2.  Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis.

Authors:  Ann N Burchell; Allita Rodrigues; Veronika Moravan; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Authors:  Andrzej Roszak; Adrianna Mostowska; Anna Sowińska; Margarita Lianeri; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2012-05-22       Impact factor: 3.201

4.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

5.  Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Authors:  Andrew W Woodham; Ross W Cheloha; Jingjing Ling; Mohammad Rashidian; Stephen C Kolifrath; Maia Mesyngier; Joao N Duarte; Justin M Bader; Joseph G Skeate; Diane M Da Silva; W Martin Kast; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2018-05-23       Impact factor: 11.151

6.  Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.

Authors:  Carolyn E Banister; Amy R Messersmith; Bo Cai; Lisa B Spiryda; Saundra H Glover; Lucia Pirisi; Kim E Creek
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

7.  Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

Authors:  Laura M Fahey; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Human papillomavirus infections among couples in new sexual relationships.

Authors:  Ann N Burchell; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.

Authors:  Ann Nielsen; Thomas Iftner; Christian Munk; Susanne K Kjaer
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.